Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Ileus Prevention in Abdominal Wall Reconstruction
NCT05985343Phase 4Completed
- Sponsor
- Clayton Petro
- Start
- Jan 2024
- Primary completion
- May 2025
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in postoperative ileus (POI), sponsored by Clayton Petro. Started Jan 2024; status: completed.
02
Drugs
Sugammadex
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05985343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05985343.